BTK inhibition by IBN has been shown to cause lymphocytosis, a process of compartment shifts of tumor cells from lymphoid tissues to the periphery, in patients with chronic lymphocytic leukemia (42) or MCL (43). The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.